Definitive Contract HHSN268201700006C
Award Date
11/15/16
Potential Completion Date
5/14/20
Potential Value
$842K
Federal Agency
National Heart Lung and Blood Institute
Awardee
University Of Illinois
Ultimate Awardee
University Of Illinois
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Chicago, IL 60612, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
23
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to the University of Illinois, doing business as The Board of Trustees of the University of Illinois, was issued by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), a civilian agency. The $633,029.25 cost-no-fee definitive contract is for biomedical research and exploratory work, with a completion date of June 3, 2013. The University of Illinois has extensive experience as both a prime contractor and subcontractor...
This is a firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to the University of Illinois (the Board of Trustees of the University of Illinois) for an in vivo drug study as part of a collaboration through the Bench to Bedside and Back Award program. The contract has a ceiling value of $16,588.53 and a performance period ending on August 31, 2026. The University of Illinois is an experienced federal contractor, holding numerous...
This is a $19,006.85 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to the University of Illinois. The contract is for performing an in vivo drug study as part of a collaboration through the Bench to Bedside and Back award program. The contract has no set-aside designation. The University of Illinois is a prominent public land-grant research university with extensive experience in federal contracting and grant work across...
The University of Illinois, doing business as The Board of Trustees of the University of Illinois, has been awarded a $886,805 definitive cost-no-fee contract from the National Heart, Lung, and Blood Institute to support the Vascular Interventions/Innovations and Therapeutic Advances program. Under this award, the University will conduct research into selective inhibitors of integrin outside-in signaling as a new generation of anti-thrombotics. The potential value of $886,805.38 reflects the...
This is a $928,761.27 definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the University of Illinois to develop a novel drug-based therapy for the treatment of vascular leakage. The contract does not have a set-aside designation. The University of Illinois, as the prime contractor, will conduct the research and development work on this project, which aims to advance new treatments for vascular leakage, a...
This federal contract award was made by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to the University of Illinois, doing business as The Board of Trustees of the University of Illinois. The $1,335,260.77 award is for the HCHS Field Center Illinois project, with a completion date of November 30, 2018. The contract type is a delivery order with a cost-no-fee pricing structure. There was no set-aside designation for this award....
The University of Illinois, doing business as The Board of Trustees of the University of Illinois, has been awarded a $270,179 delivery order against the Pharmacology and Toxicology for Therapeutics Program (PTTP) indefinite delivery/indefinite quantity (IDIQ) contract by the National Institutes of Health's National Institute on Drug Abuse. The delivery order is for Performance Area 1, which involves management and operations support. No set-aside designation was used for this award. Place of...
The U.S. Department of Health and Human Services, National Institutes of Health (NIH) National Heart Lung and Blood Institute awarded a $203,904 Delivery Order to the Trustees of Indiana University, doing business as Indiana University Iupui, a non-profit state-controlled institution of higher learning. The award is for the GTRP Lentivirus Vector Production Core Lab (Task Order 7, Task Area B) for fiscal year 2015. The contract does not have a set-aside designation. Indiana University has...
This federal contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Heart Lung and Blood Institute to Trustees of Indiana University, doing business as Indiana University Iupui, a non-profit organization and state-controlled institution of higher learning. The contract, with a potential value of $196,248.34, is for the GTRP Lentivirus Vector Production Core Lab to provide services from December 5, 2014 to May 31, 2017. The...
The University of Illinois, doing business as The Board of Trustees of the University of Illinois, was awarded a $3,500 cost-plus-fixed-fee delivery order against the PREVENT Preclinical Drug Development Program master indefinite-delivery/indefinite-quantity contract held by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. The delivery order is to provide a contract orientation and kickoff meeting in Bristol,...